Canada's Quality of Life Hub is currently in development. We need your help! If you have ideas or thoughts for what you'd like to see on the Hub, Statistics Canada would love to hear about it. Your input is invaluable as we continue to develop the Quality of Life Hub.
Cost-related non-adherence to prescription medication
Domain
Health
Subdomain
Healthy care systems
Indicator
Cost-related non-adherence to prescription medication
Definition
Proportion of the population who delayed or did not fill a prescription, or reduced or skipped doses of medication because of the cost, in the past year.
Measurement
Cost-related non-adherence (CRNA) to prescription medication measures the proportion of the population who modified their medication routines due to economic reasons in the past year. This includes delaying or not filling a prescription and/or skipping or reducing doses of medication to make the prescription last longer.
This indicator is measured in the Survey on Health Care Access and Experiences (SHCAE-PSC), the Canadian Community Health Survey (CCHS) and the Survey on Access to Health Care and Pharmaceuticals During the Pandemic (SAHCPDP).
In the SHCAE and SAHCPDP, survey respondents are asked:
In the past 12 months, did you do any of the following because of the cost of your prescription medication?
- Not fill or collect a prescription medication
- Skip doses of your medication
- Reduce the dosage of your medication
- Delay filling a prescription
- None of the above
CCHS, survey respondents are asked:
During the last 12 months, was there a time when you did not fill or collect a prescription for your medicine, or you skipped doses of your medicine because of the cost?
- Yes
- No
- Not applicable, [I] had no medication prescription to fill in the last 12 months
In the last 12 months, was there a time when you reduced the dosage of your medication or delayed filling your prescription, because of the cost?
- Yes
- No
Data sources
This indicator is measured through multiple Statistics Canada surveys. Estimates can vary between data sources due to differences in reference periods, targeted or sampled populations, data collection and other methodology.
Data visualizations
- Pharmaceutical access and use (Statistics Canada - Infographics, November 2, 2022)
Data analysis
- Exploring gaps in prescription drug insurance coverage among men and women in Canada using an intersectional lens (Insights on Canadian Society, January 10, 2024)
- Pharmaceutical access and use during the pandemic (Insights on Canadian Society, November 2, 2022)
- Date modified: